Neopharma Technologies Launches Series A Funding Round to Transform the Rapid Diagnostics Industry
Philidelphia USA – Neopharma Technologies is thrilled to announce the launch of its Series A Funding Round, marking a significant milestone in our mission to revolutionize the $42 billion rapid diagnostics industry. With a promising pipeline of first-adopters expected to generate $58 million across 33 companies, Neopharma Technologies is poised for extraordinary growth in 2025 and beyond. As the world’s first device-agnostic, AI-driven platform, our NEOVAULT® solution is setting new standards for innovation and efficiency in diagnostics. Built on the strongest
Read more